3 Things In Biotech, May 24: Immunotherapy Makes Yet Another Foray – Seeking Alpha
Seeking Alpha |
3 Things In Biotech, May 24: Immunotherapy Makes Yet Another Foray
Seeking Alpha Squamous cell NSCLC remains a serious treatment setting, which was already revolutionized by the introduction of immunotherapy. Now that we know a chemo-checkpoint combination can improve outcomes further, this puts us one step closer to really … |
